ArticleIn vivo (Athens, Greece)

Optimal Prognostic Factors for Metastatic and Inoperable Sarcomas Treated With Pazopanib, Eribulin, and Trabectedin.

Tadashi Iwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.